Glutazone effect on weight, lipid profile and liver enzymes in diabetics
Not Applicable
- Conditions
- Type 2 diabetes melitus.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT201209276712N2
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Patients with the age between 35 and 75 years on anti-diabetic drugs; without any history of thiazolidindione use
Exclusion criteria: patients who do not use anti diabetic drugs regularly or don’t like to continue the study; patients with cirrhosis and advance congestive heart failure
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ipid profile. Timepoint: Before and after treatment. Method of measurement: laboratory testing.;Liver enzyme. Timepoint: november 2012 to march 2013. Method of measurement: labratory.;Weight. Timepoint: november 2012 to march 2013. Method of measurement: balance.
- Secondary Outcome Measures
Name Time Method FBS. Timepoint: 2012 novamber to march2013. Method of measurement: labratory.